QQQ   398.49 (+1.86%)
AAPL   160.15 (+2.13%)
MSFT   337.87 (+2.48%)
FB   337.74 (+1.39%)
GOOGL   2,899.81 (+1.97%)
AMZN   3,579.00 (+2.12%)
TSLA   1,134.59 (+4.87%)
NVDA   327.77 (+4.04%)
BABA   131.76 (-1.19%)
NIO   39.92 (-0.18%)
CGC   11.04 (-5.56%)
AMD   158.99 (+2.70%)
GE   97.36 (-0.49%)
MU   84.60 (+1.41%)
T   23.91 (-1.28%)
F   19.71 (-0.20%)
DIS   144.72 (-2.29%)
ACB   6.45 (-5.01%)
AMC   36.30 (-3.53%)
PFE   53.68 (-0.59%)
BA   196.32 (-1.45%)
QQQ   398.49 (+1.86%)
AAPL   160.15 (+2.13%)
MSFT   337.87 (+2.48%)
FB   337.74 (+1.39%)
GOOGL   2,899.81 (+1.97%)
AMZN   3,579.00 (+2.12%)
TSLA   1,134.59 (+4.87%)
NVDA   327.77 (+4.04%)
BABA   131.76 (-1.19%)
NIO   39.92 (-0.18%)
CGC   11.04 (-5.56%)
AMD   158.99 (+2.70%)
GE   97.36 (-0.49%)
MU   84.60 (+1.41%)
T   23.91 (-1.28%)
F   19.71 (-0.20%)
DIS   144.72 (-2.29%)
ACB   6.45 (-5.01%)
AMC   36.30 (-3.53%)
PFE   53.68 (-0.59%)
BA   196.32 (-1.45%)
QQQ   398.49 (+1.86%)
AAPL   160.15 (+2.13%)
MSFT   337.87 (+2.48%)
FB   337.74 (+1.39%)
GOOGL   2,899.81 (+1.97%)
AMZN   3,579.00 (+2.12%)
TSLA   1,134.59 (+4.87%)
NVDA   327.77 (+4.04%)
BABA   131.76 (-1.19%)
NIO   39.92 (-0.18%)
CGC   11.04 (-5.56%)
AMD   158.99 (+2.70%)
GE   97.36 (-0.49%)
MU   84.60 (+1.41%)
T   23.91 (-1.28%)
F   19.71 (-0.20%)
DIS   144.72 (-2.29%)
ACB   6.45 (-5.01%)
AMC   36.30 (-3.53%)
PFE   53.68 (-0.59%)
BA   196.32 (-1.45%)
QQQ   398.49 (+1.86%)
AAPL   160.15 (+2.13%)
MSFT   337.87 (+2.48%)
FB   337.74 (+1.39%)
GOOGL   2,899.81 (+1.97%)
AMZN   3,579.00 (+2.12%)
TSLA   1,134.59 (+4.87%)
NVDA   327.77 (+4.04%)
BABA   131.76 (-1.19%)
NIO   39.92 (-0.18%)
CGC   11.04 (-5.56%)
AMD   158.99 (+2.70%)
GE   97.36 (-0.49%)
MU   84.60 (+1.41%)
T   23.91 (-1.28%)
F   19.71 (-0.20%)
DIS   144.72 (-2.29%)
ACB   6.45 (-5.01%)
AMC   36.30 (-3.53%)
PFE   53.68 (-0.59%)
BA   196.32 (-1.45%)
NASDAQ:NDRA

ENDRA Life Sciences Stock Forecast, Price & News

$1.00
+0.04 (+3.76%)
(As of 11/29/2021 11:11 AM ET)
Add
Compare
Today's Range
$0.97
$1.07
50-Day Range
$0.91
$1.90
52-Week Range
$0.70
$3.10
Volume
946 shs
Average Volume
1.25 million shs
Market Capitalization
$42.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.14
30 days | 90 days | 365 days | Advanced Chart
Receive NDRA News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.


ENDRA Life Sciences logo

About ENDRA Life Sciences

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Headlines

ENDRA Life Sciences (NASDAQ:NDRA) Issues Earnings Results
November 16, 2021 |  americanbankingnews.com
ENDRA Life Sciences (NDRA) to Release Earnings on Monday
November 10, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NDRA
Fax
N/A
Employees
18
Year Founded
N/A

Sales & Book Value

Annual Sales
$10 thousand
Book Value
$0.22 per share

Profitability

Net Income
$-11.73 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
39,220,000
Market Cap
$42.00 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
11/29/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/24/2022

MarketRank

Overall MarketRank

0.98 out of 5 stars

Medical Sector

1267th out of 1,392 stocks

Electromedical Equipment Industry

30th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions

How has ENDRA Life Sciences' stock been impacted by Coronavirus (COVID-19)?

ENDRA Life Sciences' stock was trading at $1.0029 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NDRA shares have decreased by 0.7% and is now trading at $0.9961.
View which stocks have been most impacted by COVID-19
.

When is ENDRA Life Sciences' next earnings date?

ENDRA Life Sciences is scheduled to release its next quarterly earnings announcement on Thursday, March 24th 2022.
View our earnings forecast for ENDRA Life Sciences
.

How were ENDRA Life Sciences' earnings last quarter?

ENDRA Life Sciences Inc. (NASDAQ:NDRA) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.06) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. During the same period in the previous year, the business earned ($0.15) EPS.
View ENDRA Life Sciences' earnings history
.

Who are ENDRA Life Sciences' key executives?

ENDRA Life Sciences' management team includes the following people:
  • Francois Michelon, Chairman, President & Chief Executive Officer
  • Irina Pestrikova, Chief Financial Officer & Senior Director-Finance
  • Michael Thornton, Chief Technology Officer (LinkedIn Profile)
  • Amy Sitzler, Vice President-Engineering & Programs
  • Renaud Maloberti, Chief Commercial Officer

What other stocks do shareholders of ENDRA Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Ampio Pharmaceuticals (AMPE), Bionano Genomics (BNGO), OPKO Health (OPK), TherapeuticsMD (TXMD), Vista Gold (VGZ), electroCore (ECOR) and Genocea Biosciences (GNCA).

When did ENDRA Life Sciences IPO?

(NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

What is ENDRA Life Sciences' stock symbol?

ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA."

Who are ENDRA Life Sciences' major shareholders?

ENDRA Life Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.77%), Royal Bank of Canada (0.04%) and Citadel Advisors LLC (0.04%). Company insiders that own ENDRA Life Sciences stock include Alexander Y Tokman, Anthony Digiandomenico, David R Wells, Francois Roger Michelon, Lou Basenese, Michael Milos Thornton and Renaud Bertrand Maloberti.
View institutional ownership trends for ENDRA Life Sciences
.

Which major investors are selling ENDRA Life Sciences stock?

NDRA stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada. Company insiders that have sold ENDRA Life Sciences company stock in the last year include Alexander Y Tokman, David R Wells, Francois Roger Michelon, Lou Basenese, Michael Milos Thornton, and Renaud Bertrand Maloberti.
View insider buying and selling activity for ENDRA Life Sciences
or view top insider-selling stocks.

Which major investors are buying ENDRA Life Sciences stock?

NDRA stock was bought by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, and Geode Capital Management LLC. Company insiders that have bought ENDRA Life Sciences stock in the last two years include Anthony Digiandomenico, and Lou Basenese.
View insider buying and selling activity for ENDRA Life Sciences
or or view top insider-buying stocks.

How do I buy shares of ENDRA Life Sciences?

Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ENDRA Life Sciences' stock price today?

One share of NDRA stock can currently be purchased for approximately $1.00.

How much money does ENDRA Life Sciences make?

ENDRA Life Sciences has a market capitalization of $42.00 million and generates $10 thousand in revenue each year. The company earns $-11.73 million in net income (profit) each year or ($0.39) on an earnings per share basis.

How many employees does ENDRA Life Sciences have?

ENDRA Life Sciences employs 18 workers across the globe.

What is ENDRA Life Sciences' official website?

The official website for ENDRA Life Sciences is www.endrainc.com.

Where are ENDRA Life Sciences' headquarters?

ENDRA Life Sciences is headquartered at 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105.

How can I contact ENDRA Life Sciences?

ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at (734) 335-0468 or via email at [email protected].


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.